1 / 8

Pharmacogenomics Market Size, Share, Trends, Growth and Forecast Till 2028

According to our latest study on u201cPharmacogenoics Market Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by Technology, Application, and End User,u201d the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

nikhilghodse94
Download Presentation

Pharmacogenomics Market Size, Share, Trends, Growth and Forecast Till 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacogenomics Market Global Analysis and Forecast to 2028 Published Date : Feb 2022 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) 2

  3. Email: sales@theinsightpartners.com Pharmacogenomics Market Overview  The Pharmacogenomics Market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028.  The increasing prevalence of chronic diseases is one of the most critical factors driving the growth of the market. Many older adults (>60%) suffer from two or more chronic conditions. Twin studies stated that genes can cause chronic conditions, such as cardiovascular disease (CVDs), diabetes, obesity, RA, Alzheimer's disease (AD), and depression. Using molecular genetic data from genome-wide association studies (GWAS), it is now possible to measure individual-level risks for these chronic diseases. According to the Centers for Disease Control and Prevention (CDC), in 2020, nearly 6 in 10 people in the US suffered from at least one chronic disease, and 4 in 10 people had two or more chronic conditions.The increasing incidence of chronic diseases is triggering the demand of pharmacogenomic technologies for developing novel therapies. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Product (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others)  Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others)  End-User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) Download Sample Here 4

  5. Email: sales@theinsightpartners.com $50,000 Pharmacogenomic s Market Value $40,000 $30,000 CAGR of 10.3% $20,000 (2021 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  F. Hoffmann-la Roche Ltd  Abbott  Oxford Nanopore Technologies  Thermo Fisher Scientific Inc  Illumina, Inc; QIAGEN  Agilent Technologies, Inc  Myriad Genetics, Inc  Admera Health  Dynamic DNA Laboratories Download Sample Here 6

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related